Literature DB >> 13284667

Treatment of arterial hypertension with rescinnamine, a new alkaloid isolated from Rauwolfia serpentina.

G LEMIEUX, A DAVIGNON, J GENEST.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13284667      PMCID： PMC1826433     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Clinical uses of rauwolfia. I. In arterial hypertension.

Authors:  J GENEST; L ADAMKIEWICZ; R ROBILLARD; G TREMBLAY
Journal:  Can Med Assoc J       Date:  1955-04-01       Impact factor: 8.262

2.  Comparison of rescinnamine and reserpine as hypotensive agents.

Authors:  F H SMIRK; E G McQUEEN
Journal:  Lancet       Date:  1955-07-16       Impact factor: 79.321

3.  Pharmacological studies with rescinnamine, a new alkaloid isolated from Rauwolfia serpentina.

Authors:  G CRONHEIM; W BROWN; J CAWTHRONE; M I TOEKES; J UNGARI
Journal:  Proc Soc Exp Biol Med       Date:  1954-05
  3 in total
  3 in total

1.  Rescinnamine in treatment of hypertension in hospital clinic and in general practice.

Authors:  R FIFE; J C MACLAURIN; J H WRIGHT
Journal:  Br Med J       Date:  1960-12-24

2.  Treatment of arterial hypertension with recanescine: a new alkaloid isolated from Rauwolfia.

Authors:  J M PEPIN; B THERIEN; B VITYE; G LEMIEUX; J GENEST
Journal:  Can Med Assoc J       Date:  1957-03-15       Impact factor: 8.262

3.  Management and concept of human arterial hypertension.

Authors:  J GENEST
Journal:  Can Med Assoc J       Date:  1956-10-15       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.